Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 23:9:e57877.
doi: 10.7554/eLife.57877.

Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization

P J Klasse  1 , John P Moore  1
Affiliations
Review

Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization

P J Klasse et al. Elife. .

Abstract

We review aspects of the antibody response to SARS-CoV-2, the causative agent of the COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from recovered patients, monoclonal antibodies against the viral S-protein, and soluble forms of the receptor for the virus, angiotensin converting enzyme 2. The development of vaccines against SARS-CoV-2, an essential public health tool, will also be informed by an understanding of the antibody response in infected patients. Although virus-neutralizing antibodies are likely to protect, antibodies could potentially trigger immunopathogenic events in SARS-CoV-2-infected patients or enhance infection. An awareness of these possibilities may benefit clinicians and the developers of antibody-based therapies and vaccines.

Keywords: COVID-19; SARS-CoV-2; antibodies; infectious disease; microbiology; plasma; therapy; vaccine.

PubMed Disclaimer

Conflict of interest statement

PK, JM No competing interests declared

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Accorsi P, Berti P, Angelis de. Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19. Blood Transfusion = Trasfusione Del Sangue. 2020;18:163–166. doi: 10.1016/j.transci.2020.102817. - DOI - PMC - PubMed
    1. Agrawal AS, Tao X, Algaissi A, Garron T, Narayanan K, Peng BH, Couch RB, Tseng CT. Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus. Human Vaccines & Immunotherapeutics. 2016;12:2351–2356. doi: 10.1080/21645515.2016.1177688. - DOI - PMC - PubMed
    1. Ahn JY, Sohn Y, Lee SH, Cho Y, Hyun JH, Baek YJ, Jeong SJ, Kim JH, Ku NS, Yeom J-S, Roh J, Ahn MY, Chin BS, Kim YS, Lee H, Yong D, Kim HO, Kim S, Choi JY. Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory distress syndrome in Korea. Journal of Korean Medical Science. 2020;35:e149. doi: 10.3346/jkms.2020.35.e149. - DOI - PMC - PubMed
    1. Akerström S, Tan YJ, Mirazimi A. Amino acids 15-28 in the ectodomain of SARS coronavirus 3a protein induces neutralizing antibodies. FEBS Letters. 2006;580:3799–3803. doi: 10.1016/j.febslet.2006.06.002. - DOI - PMC - PubMed
    1. Amanat F, Stadlbauer D, Strohmeier S, Nguyen THO, Chromikova V, McMahon M, Jiang K, Arunkumar GA, Jurczyszak D, Polanco J, Bermudez-Gonzalez M, Kleiner G, Aydillo T, Miorin L, Fierer DS, Lugo LA, Kojic EM, Stoever J, Liu STH, Cunningham-Rundles C, Felgner PL, Moran T, García-Sastre A, Caplivski D, Cheng AC, Kedzierska K, Vapalahti O, Hepojoki JM, Simon V, Krammer F. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nature Medicine. 2020;5:12. doi: 10.1038/s41591-020-0913-5. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances